Fractional nitric oxide concentration in exhaled breath predicts short term response to high-dose inhaled corticosteroid treatment: a single centered pre-post study
Not Applicable
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000034005
- Lead Sponsor
- Department of Pulmonary Medicine, Kameda Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
We will exclude patients taking oral or inhaled corticosteroids within 1 month of trial entry. We will also exclud unstable COPD patients who have an exacerbation within 6 weeks of trial entry or have severe intercurrent diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is change of post-bronchodilator FEV1 by using high-dose ICS.
- Secondary Outcome Measures
Name Time Method The secondary outcomes are improvement of CAT score, %FEV1, %FVC.